Aegis Capital Starts Harrow Health (HROW) at Buy
Tweet
Share
E-mailGet Alerts HROW Hot Sheet
Price: $41.78 +5.72%
Rating Summary:
8 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Rating Summary:
8 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Join SI Premium – FREE
Aegis Capital analyst Nathan Weinstein initiates coverage on Harrow Health (NASDAQ: HROW) with a Buy rating and a price target of $15.00.
For an analyst ratings summary and ratings history on Harrow Health click here. For more ratings news on Harrow Health click here.
Shares of Harrow Health closed at $9.68 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wedbush Starts Aktis Oncology (AKTS) at Outperform
- Oppenheimer Starts Healthcare Services Group (HCSG) at Outperform
- BMO Capital Starts Perspective Therapeutics Inc (CATX) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
